Procter and Gamble (P&G) Philippines, alongside P&G Health, stands at the forefront of revolutionizing the landscape of Peripheral Neuropathy (PN). Their collaborative efforts aim to enhance the lives of millions impacted by this condition, leading a transformative discourse on PN. During the #KNOWTHESIGNS Scientific Forum on World Diabetes Day, held last November 14, 2023, groundbreaking insights were revealed, marking a pivotal moment in reshaping our comprehension of PN—a condition affecting over 50 million individuals worldwide.
A key highlight of the forum was the presentation of the NENOIN Study results, unveiling the efficacy of a fixed dose combination of B vitamins (B1, B6, and B12) in significantly enhancing nerve function. These findings serve as a vital guide for managing Peripheral Neuropathy, offering tangible hope to millions globally. Despite the forum’s timing, the enduring impact of these revelations continues to drive meaningful change.
Understanding the Scope of Peripheral Neuropathy:
Peripheral Neuropathy affects a staggering 50 million individuals worldwide, posing considerable challenges for those with diabetes and pre-diabetes. Common symptoms such as numbness, tingling, and burning sensations in the hands and feet significantly impact the quality of life for individuals grappling with this condition.
Diabetes Mellitus Type 2 stands as the primary culprit behind PN, with the increasing prevalence of this condition closely correlated to the rising diabetic population. Diabetic Peripheral Neuropathy (DPN) arises from nerve damage, significantly hindering individuals’ ability to comfortably navigate their daily lives. Symptoms encompass numbness, tingling, prickling, and burning sensations in the hands and feet. Alongside diabetes, high-risk factors contributing to peripheral nerve damage include B vitamin deficiency and polymedication. Studies conducted globally indicate that up to 80% of PN cases go undiagnosed and untreated, underscoring the urgency for awareness and intervention.
P&G’s Comprehensive Approach:
P&G Health is dedicated to tackling the complex facets of Peripheral Neuropathy by introducing comprehensive solutions aimed at delivering relief and enhancing the quality of life for individuals grappling with the daily challenges of PN.
Key Components of P&G’s Peripheral Neuropathy Management Strategy:
1. Innovative Research: A leader in Nerve Health, P&G Health invests in continuous research, exemplified by studies like the NENOIN Study, to uncover effective solutions for Peripheral Neuropathy. This commitment to innovation underlines P&G’s dedication to improving outcomes for those living with PN. PN is associated with poor functional mobility and compromised motor symptoms, in addition to sensory symptoms. These symptoms significantly worsen the quality of life of patients. Results from the NENOIN study concluded that the synergistic combination of vitamins B1, B6, and B12 can not only relief symptoms but also significantly improve nerve function in patients with PN which is a critical learning. This further underlines how early screening for PN and timely treatment can help improve quality of life and treatment outcomes
2. Vitamin B Supplementation: Besides diabetes mellitus, aging, alcoholism, and B vitamins deficiencies are other high-risk factors leading to peripheral nerve damage. Vitamin B1, B6, and B12 play essential roles in the maintenance of a healthy nervous system. Vitamin B1 provides energy to the nerves, vitamin B6 helps with signal transmission in nerves, while vitamin B12 helps with neuronal regeneration. combination of vitamin B1, B6 and B12 that is scientifically proven to repair nerve damage, restore nerve function and regenerate nerves to relieve neuropathy symptoms.
3. Pharmacist Engagement: Acknowledging the integral role of pharmacists in patient care, P&G advocates for their active involvement. By providing guidance on lifestyle modifications and recommending over-the-counter treatments, pharmacists play a vital role in supporting individuals with PN. A Speaker at the Forum, Dr. Kenny P Merin (Pharmacist, and Assistant Vice President, Academics & Research of Lyceum of the Philippines University Davao – Philippines) shared, “Pharmacists are an integral part of the healthcare team and can provide valuable support to patients with PN, yet often we are underutilized. Pharmacists are often the first point of contact and can drive early awareness of patient’s condition, offer guidance on lifestyle modifications, and help optimize medication regimens. Pharmacists can also recommend over-the-counter treatments (e.g., therapeutic dose of Neurotropic B vitamins) for PN symptom relief. By actively engaging with patients and healthcare professionals, let’s join hands to improve PN patients’ long-term health and well-being.”
4. AI-Powered Awareness: P&G’s ongoing #KnowtheSigns campaign leverages Artificial Intelligence to make the often-invisible conditions of PN and Vitamin B deficiency more visible and relatable to consumers. Early diagnosis is emphasized as a critical factor in enabling better treatment outcomes.
5. Collective Stakeholder Efforts: Insights from healthcare professionals around the globe underscore the importance of collaborative efforts, education, and early intervention. As a partner to International Diabetes Federation (IDF), P&G Health is committed to continued efforts to raise awareness on Diabetes and its associated complications including Peripheral Neuropathy and Vitamin B Deficiency. The goal is to create a comprehensive support system that addresses the challenges posed by Peripheral Neuropathy on a global scale.
“Our #KnowtheSigns campaign represents a revolutionary shift in health awareness. By leveraging Artificial Intelligence (AI), we’re making the invisible conditions of PN & Vitamin B deficiency more visible and relatable to consumers for the first time. Our aim is to illuminate daily struggles and symptoms, fostering understanding about this condition. Many are unaware that early diagnosis can significantly improve treatment outcomes and quality of life; damaged nerves can even regenerate if the damage isn’t too severe,” explained Aalok Agrawal, Senior Vice-President, P&G Health, Asia, India, Middle East & Africa.
As P&G Health continues to pioneer innovations in Peripheral Neuropathy, the focus remains steadfast on providing solutions that elevate the overall quality of life for those impacted. The ongoing dedication to research, awareness, and comprehensive care reinforces P&G Health’s position as a frontrunner committed to better outcomes for individuals dealing with Peripheral Neuropathy.
